Literature DB >> 12791806

The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study.

J M Raboud1, M C Boily, J Rajeswaran, M V O'Shaughnessy, M T Schechter.   

Abstract

OBJECTIVE: To determine the impact of the implementation of a needle-exchange program (NEP) on the spread of human immunodeficiency virus (HIV) in an injection drug user (IDU) community. We conducted a Monte Carlo simulation study of a theoretical population of 10000 IDUs. The population was followed monthly from 1984 to 2000. HIV was assumed to be transmitted only by needle sharing. The NEP was introduced in 1989 and evaluated over a period of 11 years. The impacts of the proportion of the population attending the NEP, the risk level of IDUs attending the NEP, the reduction in needle-sharing frequency, and the number of new needle-sharing partners acquired at the NEP on prevalence and incidence of HIV were determined. Increasing the proportion of the population who always attend the NEP and eliminating needle-sharing incidents among IDUs who always attended the NEP were the most effective ways of reducing the spread of HIV. Attracting high-risk users instead of lower risk users to the NEP also reduced the spread of HIV, but to a lesser extent. NEPs are effective at reducing the spread of HIV; even under the worst case scenario of low risk users more likely to attend the NEP, one additional partner per month as a result of attending the NEP, and poor NEP attendance, the estimated prevalence was still less than that from the scenario without an NEP. Under our model, NEPs were shown to reduce the spread of HIV significantly. Efforts should be focused on getting as many IDUs as possible to become regular NEP attenders and stop sharing needles rather than partially reducing the frequency of sharing by a larger number of IDUs.

Entities:  

Mesh:

Year:  2003        PMID: 12791806      PMCID: PMC3456277          DOI: 10.1093/jurban/jtg033

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  47 in total

1.  Evaluating effectiveness of syringe exchange programmes: current issues and future prospects.

Authors:  F I Bastos; S A Strathdee
Journal:  Soc Sci Med       Date:  2000-12       Impact factor: 4.634

2.  High street prices of syringes correlate with strict syringe possession laws.

Authors:  J D Rich; C K Foisie; C W Towe; M McKenzie; C M Salas
Journal:  Am J Drug Alcohol Abuse       Date:  2000-08       Impact factor: 3.829

3.  Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.

Authors:  J A Taussig; B Weinstein; S Burris; T S Jones
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

4.  Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.

Authors:  C Hartgers; E J van Ameijden; J A van den Hoek; R A Coutinho
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

5.  HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics.

Authors:  T Rhodes; A Ball; G V Stimson; Y Kobyshcha; C Fitch; V Pokrovsky; M Bezruchenko-Novachuk; D Burrows; A Renton; L Andrushchak
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

6.  Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health.

Authors:  T W Valente; R K Foreman; B Junge; D Vlahov
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

7.  Cost-effectiveness of syringe exchange as an HIV prevention strategy.

Authors:  F N Laufer
Journal:  J Acquir Immune Defic Syndr       Date:  2001-11-01       Impact factor: 3.731

8.  Research, politics, and needle exchange.

Authors:  D C Des Jarlais
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

9.  Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS).

Authors:  E R Monterroso; M E Hamburger; D Vlahov; D C Des Jarlais; L J Ouellet; F L Altice; R H Byers; P R Kerndt; J K Watters; B P Bowser; M D Fernando; S D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2000-09-01       Impact factor: 3.731

10.  Health risks and opportunities for harm reduction among injection-drug-using clients of Saskatoon's needle exchange program.

Authors:  M L Laurie; K L Green
Journal:  Can J Public Health       Date:  2000 Sep-Oct
View more
  13 in total

1.  Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.

Authors:  Valerie J Rose; Glenn Backes; Alexis Martinez; Willi McFarland
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

Review 2.  Deadly public policy: what the future could hold for the HIV epidemic among injection drug users in Vancouver.

Authors:  Michael V O'Shaughnessy; Robert S Hogg; Steffanie A Strathdee; Julio S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

3.  Primary and secondary analysis of local elected officials' decisions to support or oppose pharmacy sale of syringes in California.

Authors:  Glenn Backes; Valerie J Rose
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

4.  Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.

Authors:  J F G Monteiro; D J Escudero; C Weinreb; T Flanigan; S Galea; S R Friedman; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-01-12       Impact factor: 2.451

5.  Identifying heterogeneity among injection drug users: a cluster analysis approach.

Authors:  Souradet Y Shaw; Lena Shah; Ann M Jolly; John L Wylie
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

6.  A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies.

Authors:  Brandon D L Marshall; Magdalena M Paczkowski; Lars Seemann; Barbara Tempalski; Enrique R Pouget; Sandro Galea; Samuel R Friedman
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

7.  Bundling occupational safety with harm reduction information as a feasible method for improving police receptiveness to syringe access programs: evidence from three U.S. cities.

Authors:  Corey S Davis; Leo Beletsky
Journal:  Harm Reduct J       Date:  2009-07-14

8.  Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1.

Authors:  João Dinis de Sousa; Carolina Alvarez; Anne-Mieke Vandamme; Viktor Müller
Journal:  Viruses       Date:  2012-10-03       Impact factor: 5.048

Review 9.  Combination prevention: new hope for stopping the epidemic.

Authors:  Sten H Vermund; Richard J Hayes
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

10.  Changing risk behaviours and the HIV epidemic: a mathematical analysis in the context of treatment as prevention.

Authors:  Bojan Ramadanovic; Krisztina Vasarhelyi; Ali Nadaf; Ralf W Wittenberg; Julio S G Montaner; Evan Wood; Alexander R Rutherford
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.